PRIMOLUT DEPOT

Indications

• Metabolic disorders
• Food additive
• Potential role in cannabinoid synthesis

Dosage

Children: Refer to the BNF for Children for appropriate dosing information.

Adults: Refer to specific clinical guidelines or consult the BNF for appropriate dosing information.

Mechanism of action

Caproate acts as a precursor in the cannabinoid biosynthesis pathway. It influences lipid metabolism and may modulate various physiological processes through its interaction with fatty acid receptors, although specific receptor interactions and downstream effects require further elucidation.

Pharmacodynamics

Caproate is associated with lipid metabolism and may have roles in energy production and cellular signaling. Its effects can vary based on concentration and biological context, contributing to metabolic processes and potentially impacting appetite regulation and energy homeostasis.

Pharmacokinetics

Caproate is absorbed through the gastrointestinal tract and metabolized in the liver. It undergoes β-oxidation to produce energy and can be incorporated into various lipid structures. The pharmacokinetic profile, including absorption, distribution, metabolism, and excretion, can be influenced by factors such as diet and individual metabolic rates.

Pregnancy

There is limited data on the use of caproate in pregnancy. Caution is advised.

Breast-feeding

Caution is advised as the effects on the nursing infant are not well studied.

Storage

Store in a well-closed container at room temperature, away from light.

Indications

• Prevention of preterm birth in high-risk pregnant women
• Hormone replacement therapy for menopausal symptoms
• Management of abnormal uterine bleeding
• Treatment of amenorrhea

Dosage

Children: Refer to the specific product guidelines or BNF for Children for detailed dosing information.

Adults: Refer to the specific product guidelines or BNF for detailed dosing information.

Mechanism of action

Hydroxyprogesterone binds to progesterone receptors, leading to the regulation of gene expression that controls the menstrual cycle and pregnancy. It inhibits the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland, thereby reducing ovarian follicular development. Additionally, it promotes the secretory phase of the endometrium, facilitates implantation, and reduces uterine contractions.

Pharmacodynamics

Hydroxyprogesterone exhibits progestational effects which include the preparation of the endometrium for implantation of a fertilized ovum, maintenance of the endometrial lining during pregnancy, and inhibition of uterine contractions. Its effects on the body include alterations in metabolism, immune response, and modulation of other hormones, leading to overall stability during pregnancy.

Pharmacokinetics

Hydroxyprogesterone is usually administered via intramuscular injection, where it is absorbed into systemic circulation. It has a relatively long half-life, allowing for prolonged therapeutic effects. The drug is metabolized primarily in the liver, and its metabolites are excreted mainly through urine. The pharmacokinetics can vary depending on the route of administration and the formulation used.

Contra-indications

• Hypersensitivity to hydroxyprogesterone or any of its components
• Undiagnosed vaginal bleeding
• History of thrombosis or thromboembolic disorders
• Active liver disease
• Known or suspected malignancy of the breast or genital organs

Adverse effects

• Nausea
• Headache
• Dizziness
• Fatigue
• Breast tenderness
• Mood changes
• Weight gain
• Vascular complications such as thrombosis

Interactions

• Anticoagulants - may enhance their effects, requiring close monitoring
• Corticosteroids - may increase their effects
• Antiepileptics - may reduce the efficacy of hydroxyprogesterone

Precautions

• Monitor for signs of thrombosis
• Use with caution in patients with a history of depression
• Regular monitoring of liver function tests is recommended
• Assess for potential interactions with other medications

Pregnancy

Hydroxyprogesterone is used in pregnancy to support luteal phase and prevent preterm birth in women with a history of preterm birth.

Breast-feeding

Hydroxyprogesterone is excreted in breast milk; caution is advised when used during breastfeeding.

Storage

Store at room temperature, away from moisture and heat. Keep the container tightly closed.

Formulations

• Injection (oil-based solution)
• Capsules